SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)
[v160024_ex99-1.htm 2 EX-99.1]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: v160024_ex99-1.htm 2 EX-99.1
[v160024_ex99-1.htm 2 EX-99.1]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: (Original Filing)
[Skystar Wins Local Government Bids to Expand Product Distribution XI'AN, CHINA, September 9, 2009ystar Bio-Pharmaceuticalmpany Our Praziquantel tablets position us toptureditional market share local governmentsntinue to move toward the mostst effective solutions rather than utilizing State-Owned Enterprise (SOE) products,id Mr. Weibing Lu,ystars Chairman and CEO. These newntracts demonstrateystars industry leadership position and signify important inroads]
SKBI [SKYSTAR BIO-PHARMACEUTICAL] 8-K: Skystar Wins Local Government Bids to Expand Product
[Skystar Wins Local Government Bids to Expand Product Distribution XI'AN, CHINA, September 9, 2009ystar Bio-Pharmaceuticalmpany Our Praziquantel tablets position us toptureditional market share local governmentsntinue to move toward the mostst effective solutions rather than utilizing State-Owned Enterprise (SOE) products,id Mr. Weibing Lu,ystars Chairman and CEO. These newntracts demonstrateystars industry leadership position and signify important inroads]
CPHI [CHINA PHARMAS,] 8-K: (Original Filing)
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of the Company by offering opportunities to directors, officers, employees and eligible consultants of the Company to acquire and maintain stock ownership in the Company]
CPHI [CHINA PHARMAS,] 8-K: ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS;
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of the Company by offering opportunities to directors, officers, employees and eligible consultants of the Company to acquire and maintain stock ownership in the Company]
CPHI [CHINA PHARMAS,] 8-K: (Original Filing)
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]
CPHI [CHINA PHARMAS,] 8-K: ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS;
[ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS;MPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS. The purpose of the 2009 Stock Option Plan is to enhance the long-term stockholder value of thempany by offering opportunities to directors, officers, employees and eligiblensultants of thempany to acquire and maintain stock ownership in thempany]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: (Original Filing)
[Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferential Income Tax Rate Extended through 2011 XI'AN, CHINA, September 2, 2009 — Skystar Bio-Pharmaceutical Company High Technology Enterprise Certificates are awarded to qualified enterprises that meet the following criteria: developing core intellectual property rights, receiving over 60% of their annual revenues from high-technology products/services, and perform highly technical research and development. Skystar]
SKBI [SKYSTAR BIO-PHARMACEUTICAL CO] 8-K: Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferential
[Skystar Bio-Pharmaceutical Awarded High Technology Enterprise Certificate Preferential Income Tax Rate Extended through 2011 XI'AN, CHINA, September 2, 2009 — Skystar Bio-Pharmaceutical Company High Technology Enterprise Certificates are awarded to qualified enterprises that meet the following criteria: developing core intellectual property rights, receiving over 60% of their annual revenues from high-technology products/services, and perform highly technical research and development. Skystar]
